Stay updated on Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Sign up to get notified when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.

Latest updates to the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedImportant updates: added a government funding notice and current operating status for the NIH Clinical Center, and updated the version to v3.2.0 (removing v3.1.0).SummaryDifference3%

- Check28 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check43 days agoChange DetectedPage updated to revision v3.0.2, replacing v3.0.1; a 'Back to Top' link was removed as a minor UI change.SummaryDifference0.2%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of various insulin-related products. Notably, the previous mentions of certain insulin types and locations have been removed.SummaryDifference5%

- Check71 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.